Applications published 21 March 2007

Pyrimidine derivatives as 11beta-HSD1 inhibitors
F. Hoffmann-La Roche 1763517*

Substituted 2-alkyl quinazolinone derivatives as PARP inhibitors
Janssen Pharmaceutica 1763518*

Use of trisubstituted benzopyranones
Dr Willmar Schwabe 1763520*

1-(indole-6-carbonyl-D-phenylglycinyl)-4-(l-methylpiperidin-4-yl) piperazine D-tartrate
Eli Lilly 1763521*

Pyridin-2-one compounds and their use as modulators of the dopamine D3 receptor
Abbott 1763522*

Quinazolinedione derivatives as PARP inhibitors
Janssen Pharmaceutica 1763523*

Indole derivatives as use thereof as kinase inhibitors
Takeda San Diego 1763524*

Stable micronised candesartan cilexetil and methods for preparing thereof
Teva Pharmaceuticals 1763525*

4,6-disubstituted pyrimidines and their use as protein kinase inhibitors
Altana Pharma 1763526*

4-substituted quinoline derivatives, method and intermediates for preparing same and pharmaceutical compsns containing same
Novexel 1763527*

Pyrazolopyridine derivatives
Astellas Pharma 1763528*

A process for the preparation of risperidone
Richter Gedeon Vegy Szeti 1763529*

Imidazopyridazine diones, the production thereof, and the use of the same as a medicament
Boehringer Ingelheim International 1763530*

Hepatitis C inhibitor peptide analogues
Boehringer Ingelheim International 1763531*

1,1"-diphosphinoferrocenes having 2,2"-bound achirals or chiral radicals
Solvias 1763532*

Specific antagonist for both E- and P-selectins
GlycoMimetics 1763533*